Prabhudas Lilladher has come out with its fourth quarter (January-March’ 19) earnings estimates for the Pharma sector. The brokerage house expects Cipla to report net profit at Rs. 283.1 crores up 58.5% year-on-year (down 14.8% quarter-on-quarter). Net Sales are expected to increase by 9.5% Y-o-Y (down 2% Q-o-Q) to Rs. 3,829.1 crore.